WSJ -- In the never-ending guessing game called What Drug Company Is Going to Get Bought Next?, Bristol-Myers Squibb and Biogen Idec are popular players. As it happens, the CEOs of both companies are in the financial press this afternoon, making rather similar comments about getting acquired.
